PropertyValue
?:abstract
  • Abstract The emergence of SARS-CoV-2, the causative agent of coronavirus disease 2019 (COVID-19), represents a public health emergency of unprecedented proportion. The global containment efforts have been focused on testing, tracing of contacts and treatment (isolation) of those found COVID-19 positive. Since the whole genome sequences of a number of strains of this novel RNA virus were available in the public domain by early January 2020, a number of real-time polymerase chain reaction (RT-PCR) protocols were designed and used for diagnosis of this infection. Most RT-PCRs are designed for qualitative COVID-19 reporting (SARS-CoV-2 detected or not detected), but have been used for semi-quantitative estimation of viral load based on cycle threshold value. Our manuscript discusses the utility of quantitative PCR testing for COVID-19 and its patient management benefits.
?:creator
?:doi
  • 10.4103/ijmm.ijmm_20_380
?:doi
?:journal
  • Indian_Journal_of_Medical_Microbiology
?:license
  • els-covid
?:pdf_json_files
  • document_parses/pdf_json/1dad1669e2ddd030a032211b30e8711630ace9b4.json
?:pmcid
?:pmid
?:pmid
  • 33154236.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Elsevier; Medline; PMC
?:title
  • Can Quantitative RT-PCR for SARS-CoV-2 Help in Better Management of Patients and Control of Coronavirus Disease 2019 Pandemic
?:type
?:year
  • 2020-11-30

Metadata

Anon_0  
expand all